Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2
Conditions
Interventions
- DRUG: chemotherapy (Aracytine + Daunorubicin)
- DRUG: chemotherapy (Aracytine + Daunorubicin)
- DRUG: chemotherapy (Aracytine + Daunorubicin)
Sponsor
Acute Leukemia French Association
Collaborators